TG-1701
TG-1701-101
Phase 1 small_molecule terminated
Quick answer
TG-1701 for Non Hodgkin Lymphoma is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Non Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated